THE Food and Drug Administration on Monday approved a drug called baricitinib as the first oral tablet for treating severe alopecia areata, an autoimmune disorder affecting more than 300,000 people in the United States every year.
Alopecia causes either temporary or permanent patchy hair loss that can affect any hair-bearing site of the body, leading to emotional distress. The condition has come to the fore recently through high-profile cases including Hollywood actress Jada Pinkett Smith and congresswoman Ayanna Pressley.
"Access to safe and effective treatment options is crucial for the significant number of Americans affected by severe alopecia," said FDA official Kendall Marcus in a statement.
"Today's approval will help fulfill a significant unmet need for patients with severe alopecia areata."
Baricitinib, which is made by US pharmaceutical company Eli Lilly and known by the trade name Olumiant, belongs to a class of drugs called Janus kinase inhibitors. It works by interfering with the cellular pathway that leads to inflammation.
Its approval for use against alopecia was based on the results of two randomized, controlled clinical trials involving a total 1,200 adults with severe alopecia.
Each trial split participants into three groups: a placebo group, a group that received a two-milligram dose every day, and a group that received a four-milligram dose every day.
After 36 weeks, almost 40 percent of those on the higher dose grew back 80 percent of their scalp hair, compared to around 23 percent of the lower dose group, and five percent of the placebo group.
Around 45 percent of people in the higher dose group also saw significant eyebrow and eyelash regrowth.
The most common side effects included upper respiratory tract infections, headaches, acne, high cholesterol, and increase of an enzyme called creatine phosphokinase.
Prior treatments for alopecia included topical or oral drugs, but these have been considered experimental and none was approved.
Baricitinib was previously approved for treatment of rheumatoid arthritis, and during the Covid pandemic its license was extended to the treatment of hospitalized Covid patients.
ETX Studio
Wed Jun 15 2022
Alopecia has come to the fore recently through high-profile cases including Hollywood actress Jada Pinkett Smith. - ETX Studio
Reformasi pembangunan TVET perlu dibuat secara holistik
Reformasi pembangunan perlu dibuat secara holistik membabitkan ekosistem Pendidikan TVET sedia ada di Malaysia, kata Presiden Yayasan Mahir Malaysia, Datuk P Sri Ganesh.
AWANI-RareTV: Kampung bunian di Switzerland
Penulis J.R.R Tolkien menjadikan Lauterbrunnen sebagai latar dan insipirasi kepada penghasilan kampung 'Rivendell'.
Hubungan Klopp-Salah kembali jernih
Klopp dan Salah bertelagah di tepi padang ketika Liverpool seri 2-2 dengan West Ham minggu lalu.
Michelle Yeoh antara 19 penerima Medal Of Freedom
Presiden Amerika Syarikat Joe Biden menganugerahkan Pingat Kebebasan (Medal Of Freedom) kepada 19 penerima di White House, Washington pada Jumaat.
AWANI Pagi: Advokasi rawatan dan pemulihan dadah atas talian
Agensi AntiDadah Kebangsaan (AADK) memperkenalkan kaedah rawatan dan pemulihan secara atas talian, melihat kepada trend penagihan dadah ketika ini. Diskusinya bersama Pengarah Bahagian Rawatan Perubatan & Pemulihan AADK Siti Mariam Mursidan, dalam Awani Pagi 8.30 pagi nanti.
Letupan bom Sungai Golok: Polis mula guna kereta perisai
Kawalan dan rondaan menggunakan kenderaan itu dilaksanakan oleh Pasukan Gerakan Am (PGA) membabitkan seorang pegawai dan 13 anggota.
AWANI Ringkas: Kenaikan gaji penjawat awam mampu dilaksana
Ikuti rangkuman berita utama yang menjadi tumpuan sepanjang hari di Astro AWANI menerusi AWANI Ringkas.
Guna anak patung Doraemon untuk upacara panggil hujan
Anak patung Doraemon itu turut diarak ke sekitar jalan utama di Khao Khala selepas kawasan tersebut berdepan kemarau berpanjangan.
Isteri dibunuh dan dikerat-kerat, daging ditawar kepada jiran
Saksi memberitahu mangsa dipukul dengan kayu sebelum dibunuh kejam dan tubuhnya dikerat-kerat di tengah jalan.
AWANI Pagi: Berita tumpuan & menarik di astroawani.com [4 Mei 2024]
Antara fokus AWANI Pagi bersama Geegee Ahmad & Nursyazwani Saiful Sham
- Sambutan Hari Bomba Sedunia di Tambun, Perak
- Piala Thomas: KBS anjur tayangan perlawanan di skrin gergasi
- Sambutan Hari Bomba Sedunia di Tambun, Perak
- Piala Thomas: KBS anjur tayangan perlawanan di skrin gergasi
KKM guna Baricitinib rawat pesakit COVID-19 kategori empat dan lima
Hospital seluruh negara akan mula menggunakan ubat Baricitinib untuk rawatan kepada pesakit COVID-19 terutama pesakit kategori empat dan lima.
KKM akan guna Baricitinib cegah peralihan pesakit COVID-19 ke kategori lebih meruncing
Kementerian Kesihatan (KKM) akan menggunakan ubat Baricitinib bagi mengelakkan peningkatan atau peralihan pesakit COVID-19 ke kategori yang lebih meruncing.